New study links routine blood test marker changes to earlier detection of aggressive cancer
A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Safety-net clinics nationwide expanded heat action plans this summer to protect vulnerable populations from extreme heat-related health risks.
Read MoreThe AMA introduced a policy framework to prevent AI deepfake impersonations of physicians and protect patient safety.
Read MoreErasca’s experimental pan-RAS pill shrank tumors in 40% of advanced pancreatic and 62% of non-small cell lung cancer patients in trials.
Read MoreThe AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
Read MoreThe Pennsylvania House Health Committee voted on HB 916 to update childhood blood lead testing requirements statewide.
Read MoreOver 2,500 physicians and addiction experts gathered in Atlanta for the 13th annual Rx and Illicit Drug Summit to address the opioid crisis.
Read MoreThe FDA and CMS launched the RAPID pathway to speed Medicare coverage decisions for breakthrough medical devices through aligned reviews.
Read MoreBreast cancer cases in U.S. women under 50 increased 1.4% annually from 2012-2022, driven by aggressive tumors and advanced-stage diagnoses.
Read MoreCMS finalized the 2027 Medicare Advantage rule, enhancing quality and access but reducing plan accountability by removing some performance metrics.
Read MoreA UK study of 360,000 adults found healthy sleep patterns linked to a 26% lower risk of pneumonia over 13 years.
Read More